Search
InflaRx NV
IFRXAdd to Watchlist
1.575USD
+0.015+0.96%
Close 10-26 16:00（ET）
232.11MMarket Cap
LossP/E TTM
InflaRx NV (IFRX) Stock Price Target & Forecast
Analyst Rating
Based on 9 analysts giving stock ratings to InflaRx NV in the past month.
Buy
3 Strong Buy
5 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
7.889USD+497.64%
IFRX Analyst Recommendation Trends
In the current month, IFRX has received 5 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. IFRX average Analyst price target in the last month is 7.889.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
3
3
3
3
3
2
2
2
5
5
4
3
3
4
4
4
1
1
1
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
9
8
8
8
8
8
8
IFRX Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
18
0
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Biontech SE
BNTX
4
12
8
0
0
24
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
Cytokinetics Inc
CYTK
5
16
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
Financial Forecasting
Based on analysts' estimates, IFRX EPS is projected to reach -0.061 in FY2026Q3, following reported EPS of -0.103 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.17
-0.13
-0.07
-0.06
-0.06
Actual
-0.18
-0.09
-0.10
--
--
Surprise
-6.26%
+32.30%
-58.84%
--
--
FAQs
What is InflaRx NV's price target?
Analysts forecast that InflaRx NV's price target is USD 7.89, with the highest forecast at USD 14.00 and the lowest forecast at USD 3.00.
How have InflaRx NVIFRX's recent earnings per share performed?
The market expectation was USD -0.10, while InflaRx NVIFRX's earnings per share (EPS) for the previous quarter was USD -0.09. EPS for the next quarter is expected at USD -0.06.
What is the analyst rating for InflaRx NV?
Based on the ratings of InflaRx NV's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.